| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 09/25/2003 | WO2003077919A1 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 09/25/2003 | WO2003077912A1 Method of treatment and/or prophylaxis |
| 09/25/2003 | WO2003077901A1 Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 09/25/2003 | WO2003077899A1 Anticancer composition |
| 09/25/2003 | WO2003077684A1 Composition comprising phosphate |
| 09/25/2003 | WO2003077681A1 Preparations of plant material and animal material for food, medicaments, and body care products with an increased thiocyanate content |
| 09/25/2003 | WO2003020642A3 Precipitated aragonite and a process for producing it |
| 09/25/2003 | WO2003007924A3 Combinations comprising epothilones and pharmaceutical uses thereof |
| 09/25/2003 | WO2002098339A3 Zinc containing compositions for anti-viral use |
| 09/25/2003 | WO2002061128A3 Method of determining a chemotherapeutic regimen based on ercc1 expression |
| 09/25/2003 | WO2002013833A3 SMALL MOLECULE INHIBITORS TARGETED AT Bcl-2 |
| 09/25/2003 | WO2002011670A3 Solid forms of tin ethyl etiopurpurin and processes for producing such forms |
| 09/25/2003 | US20030181529 Method for preventing and treating peripheral neuropathy by administering selegiline |
| 09/25/2003 | US20030180770 Novel compositions and methods for the identification, assessment, prevention and therapy of ovarian cancer |
| 09/25/2003 | US20030180390 Agent for reduction of scar formation by using wound alkalinization |
| 09/25/2003 | US20030180389 Effervescent glucosamine, chondroitin and MSM formula |
| 09/25/2003 | US20030180388 Side effect reduction; administering sodium selenite and,or amifostine |
| 09/25/2003 | US20030180387 Method for increasing the antioxidative potential of selenium-containing aqueous solutions |
| 09/25/2003 | US20030180386 Aqueous metal bicarbonate solution and method of use |
| 09/25/2003 | US20030180383 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
| 09/25/2003 | US20030180381 Cobalt compound; therapy for Cmpylobacter |
| 09/25/2003 | US20030180380 Treatment of colds, flu like infections and other general nasal based infections with a solution containing iodine and other broad spectrum microbicides and a method for its use |
| 09/25/2003 | US20030180379 Microbiocides; anticancer agents; bactericides; antiinflammatory agents; fungicides; viricides |
| 09/25/2003 | US20030180378 Dry powders of metal-containing compounds |
| 09/25/2003 | US20030180375 Reduce or prevention brain damage due to neurotransmitters |
| 09/25/2003 | US20030180363 Biodegradation polymer; liquid phase polyoxyethylene glycol |
| 09/25/2003 | US20030180208 Precipitated aragonite and a process for producing it |
| 09/25/2003 | US20030180179 Adsorber containing silver particles; chemical and biological warfare |
| 09/25/2003 | US20030178374 Using silver citrate |
| 09/25/2003 | CA2478997A1 Use of copper chelating tetraamines for the treatment of cardiovascular disease and heart failure |
| 09/24/2003 | EP1346726A1 Sympathetic-activating perfume composition |
| 09/24/2003 | EP1346058A2 Adenoviral systems and the uses thereof |
| 09/24/2003 | EP1345856A2 Sodium zirconium carbonate and zirconium basic carbonate and methods of making the same |
| 09/24/2003 | EP1345687A2 Cartridges useful in cleaning dialysis solutions |
| 09/24/2003 | EP1345624A1 Induction of tolerance |
| 09/24/2003 | EP1345596A1 Solvent for liquid ingredients to be used in effervescent products |
| 09/24/2003 | CN1121980C Method for reducing the bromide content in an aqueous solution containing magnesium chloride using peroxide |
| 09/24/2003 | CN1121873C Burns and scalds treating medicine |
| 09/24/2003 | CN1121872C Gastrodia elata tea for curing hypertension |
| 09/24/2003 | CN1121870C Exterior applied medicine for treating leukoderma and its preparing process |
| 09/24/2003 | CN1121863C Process for preparing medicinal attapulgite |
| 09/18/2003 | WO2003075982A1 Multiple compartment bag assembly for dialysis fluid |
| 09/18/2003 | WO2003075971A1 Control of biodegradability of composite biomaterial |
| 09/18/2003 | WO2003075942A1 Vitamin and zinc monomethionine compositions |
| 09/18/2003 | WO2003075937A1 Chinese preparation for treating enteritis ulcer colitis and preparation method thereof |
| 09/18/2003 | WO2003075920A1 Eye drops containing tetrazole derivative |
| 09/18/2003 | WO2003075917A1 Combination therapy for treating, preventing or managing proliferative disorders and cancers |
| 09/18/2003 | WO2003075876A1 New composition including a pigment assembly comprising a mica core |
| 09/18/2003 | WO2003075841A2 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 09/18/2003 | WO2003075812A1 Controlled delivery patch of active ingredient |
| 09/18/2003 | WO2003075685A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 09/18/2003 | WO2003075664A1 Use of copper and zinc silicate for controlling microbes |
| 09/18/2003 | WO2003041681A3 Lipid carrier compositions with enhanced blood stability |
| 09/18/2003 | WO2003032928A3 Therapeutic composition and use |
| 09/18/2003 | WO2003005941A3 Insert for the treatment of dry eye |
| 09/18/2003 | US20030176514 Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate |
| 09/18/2003 | US20030176403 Combination chemotherapy |
| 09/18/2003 | US20030176397 Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced GI toxicity |
| 09/18/2003 | US20030176359 Administration of a thiol-based chemoprotectant compound |
| 09/18/2003 | US20030176317 Stabilization of hypoxia inducible factor (HIF) alpha |
| 09/18/2003 | US20030175745 Peptides with growth inhibitory action |
| 09/18/2003 | US20030175362 Disinfecting nitrous acid compositions and process for using the same |
| 09/18/2003 | US20030175361 Using selenium in combination with drugs used conventionally to treat psychiatric or neurological disorders |
| 09/18/2003 | US20030175360 Comprising locally acting anesthetic, and an antacid; treatment of gastroesophageal reflux disease |
| 09/18/2003 | US20030175359 Egg treated to add 4.2 ppm or more iodine |
| 09/18/2003 | US20030175339 Formed by direct compression; friability |
| 09/18/2003 | US20030175333 Invisible patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients onto the skin |
| 09/18/2003 | US20030175328 Patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients into the skin |
| 09/18/2003 | US20030175213 Nasal solution containing a broad spectrum microbicide and a method for its use |
| 09/18/2003 | CA2478996A1 New composition including a pigment assembly comprising a mica core |
| 09/18/2003 | CA2478685A1 Ophthalmic solutions containing tetrazole derivatives |
| 09/18/2003 | CA2478338A1 Combination therapy for treating, preventing or managing proliferative disorders and cancers |
| 09/18/2003 | CA2478177A1 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 09/18/2003 | CA2477329A1 Controlled delivery patch of active ingredient |
| 09/17/2003 | EP1344460A1 Egg having active oxygen eliminating ability and method of producing same |
| 09/17/2003 | EP1343865A1 Carrier for liquid ingredients to be used in effervescent products |
| 09/17/2003 | EP1343544A2 Uses of a medical device having a lubricious, nitric oxide-releasing coating for the therapy of vascular disorders |
| 09/17/2003 | EP1343510A1 Light stabilized antimicrobial materials |
| 09/17/2003 | EP1343489A2 Sterile bicarbonate-free dialysis concentrate solutions |
| 09/17/2003 | EP1343477A2 Treatment of inoperable tumors by stereotactic injection of microspheres |
| 09/17/2003 | EP1207875B1 Pharmaceutically stable oxaliplatinum preparation for parenteral administration |
| 09/17/2003 | EP1140013B1 Foaming antacid suspension tablets |
| 09/17/2003 | EP0588858B1 IMIDAZO 2,1-b] 3]BENZAZEPINE DERIVATIVES, COMPOSITIONS AND METHOD OF USE |
| 09/17/2003 | CN1443136A Precipitated aragonite and process for producing it |
| 09/17/2003 | CN1443064A Administration of thiol-based chemoprotectant compound |
| 09/17/2003 | CN1442173A Medicine for treating burn scald and frostbite |
| 09/17/2003 | CN1442172A External use medicine for treating blister sore |
| 09/17/2003 | CN1121441C Method of detecting lung disease |
| 09/17/2003 | CN1121229C Medicinal bag for preventing cold |
| 09/16/2003 | US6620836 Administering melatonin and magnesium compound |
| 09/16/2003 | US6620779 Administering to an individual for tumor treatment a chemotherapeutically effective amount of antitumor agent carboplatin, and erythropoietin a hematocrit elevator which is administered befor or concurrently with antitumor agent |
| 09/16/2003 | US6620427 Administering calcium compoound and fat blend |
| 09/16/2003 | US6620382 Method and compositions for treatment of cancers |
| 09/16/2003 | US6620379 Apparatus and method of treatment of wounds, burns and immune system disorders |
| 09/16/2003 | CA2309573C Antiperspirant suspensions containing finely divided aluminium and zirconium, having better effectiveness and a process for their manufacture |
| 09/12/2003 | WO2003074547A2 Biologically active complex comprising alpha-lcatalbumin or a variant thereof, and a cofactor |
| 09/12/2003 | WO2003074098A1 Modified phosphocalcic compound, injectable composition containing same |
| 09/12/2003 | WO2003074082A1 Formulations and methods of using nitric oxide mimetics in cancer treatment |
| 09/12/2003 | WO2003074061A1 Electrolyte purgative |
| 09/12/2003 | WO2003074043A1 Body temperature elevating agents |